Is Jaguar Health Stock Halal?
Table of Contents
How much of Jaguar Health’s revenue comes from haram?
Jaguar Health develops plant-based, non-opioid prescription medicines for people and animals with gastrointestinal distress, specifically chronic, debilitating diarrhea.
Jaguar Health earns its revenue primarily from the following revenue sources:
- Human Health:
Includes revenue generated from selling human drug Mytesi by Jaguar’s wholly-owned subsidiary, Napo Pharmaceuticals, Inc.
- Animal Health:
Includes revenue generated from selling animal products branded as Neonorm Calf and Neonorm Foal.
The contributions from each of Jaguar Health’s revenue segments in their Q2 2021 report were as follows:
Practical Islamic Finance concludes:
None of Jaguar Health’s revenue comes from anything inherently haram.
Does Jaguar Health rely on interest to operate?
[wbcr_php_snippet id=”11367″]
What is Jaguar Health’s Environmental, Social, and Governance (ESG) Impact?
Environment
Since 2001, Jaguar Health has planted more than 800,000 Croton lechleri trees in Peru in its sustainable harvesting program.
Social
No notable social highlights.
Governance
No notable governance highlights.
Practical Islamic Finance concludes:
Jaguar Health has a net positive ESG impact.
Comfort Rating
From Jaguar Health’s business, financial, and ESG reviews, Practical Islamic Finance rates Jaguar Health’s stock as:
Uncomfortable to invest in from a halal perspective.
Justification for our rating
Jaguar Health’s consistent elevated use of interest to run its operations suggests a systemic reliance on Riba. This causes Practical Islamic Finance to be Uncomfortable investing in the company from a Halal perspective.